Core Viewpoint - The company has a significant number of drug approvals and ongoing projects, indicating a robust pipeline and commitment to compliance with national standards [1] Group 1: Drug Approvals and Production - As of June 30, 2025, the company holds a total of 1,478 drug approval numbers [1] - The company currently has 840 drug specifications in production [1] Group 2: Consistency Evaluation and R&D Projects - The company has completed a total of 151 projects that have passed consistency evaluation, including those deemed equivalent [1] - The company is actively engaged in various research and development projects, although specific numbers for ongoing projects were not disclosed [1] Group 3: National Drug Lists - The company has multiple products included in the National Essential Medicines List and the national-level Basic Medical Insurance [1]